ArticleInternational journal of molecular sciences2026

Computational Repurposing of FDA-Approved Drugs as Candidate MMP2 Inhibitors with Putative MMP3 Cross-Activity.

Saad Zekri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.